title: Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
authors.affiliation: Internal Medicine Department, Ankara Numune Hospital, Ankara, Turkey.
authors.forename: Engin
authors.initials: E
authors.lastname: Sennaroglu
authors.forename: Sebnem
authors.initials: S
authors.lastname: Karakan
authors.forename: Mansur
authors.initials: M
authors.lastname: Kayatas
authors.forename: Saadet
authors.initials: S
authors.lastname: Akdur
authors.forename: Hulki
authors.initials: H
authors.lastname: Genc
authors.forename: Tarkan
authors.initials: T
authors.lastname: Karakan
authors.forename: Rifki
authors.initials: R
authors.lastname: Ucler
authors.forename: Cem
authors.initials: C
authors.lastname: Ozisler
authors.forename: Yuksel
authors.initials: Y
authors.lastname: Urun
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D004487:Edema / Q000139:chemically induced*; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors; D011707:Pyloric Stenosis / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013454:Sulfoxides / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D013454:Sulfoxides; D000077402:Pantoprazole; D009853:Omeprazole